Qnext
Total Payments
$81,621
Transactions
4
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $34,742 | 1 | 0 |
| 2019 | $46,879 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $81,621 | 4 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| In Vitro Diagnostic Device Grifols QNext and PT, APTT, Fibrinogen Clauss, TT reagents | Grifols Diagnostic Solutions, Inc. | $35,208 | 0 |
| In Vitro Diagnostic Device Grifols QNext and PT, APTT, Fibrinogen Clauss, TT reagents DGHS01a | Grifols Diagnostic Solutions, Inc. | $34,742 | 0 |
| Sample Collection for the Validation of the Cut-Off for the VTE Exclusion Study | Grifols Diagnostic Solutions, Inc. | $11,671 | 0 |
Top Doctors Receiving Payments for Qnext
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Sacramento, CA | $81,621 | 4 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $81,621
- Total Doctors 0
- Transactions 4
About Qnext
Qnext is a device associated with $81,621 in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Grifols Diagnostic Solutions, Inc..
Payment data is available from 2019 to 2020. In 2020, $34,742 was paid across 1 transactions to 0 doctors.
The most common payment nature for Qnext is "Unspecified" ($81,621, 100.0% of total).
Qnext is associated with 3 research studies, including "In Vitro Diagnostic Device Grifols QNext and PT, APTT, Fibrinogen Clauss, TT reagents" ($35,208).